vTv Therapeutics (VTVT) Operating Margin Growth (3y) (2017 - 2024)

vTv Therapeutics (VTVT) Operating Margin Growth (3y) (2017 - 2024) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin Growth (3y) (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn 9,942.00
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn 530.00
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn -1,211.00
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn -623.00
9 Revolution Medicines 37.35 Bn 37.35 Bn - -
10 vTv Therapeutics 19.21 Mn 19.21 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2024 9.47 Mn
Mar 31, 2024 -12,906.00
Dec 31, 2022 2.08 Mn
Jun 30, 2022 -4.45 Mn
Mar 31, 2022 14,142.00
Dec 31, 2021 -12.34 Mn
Sep 30, 2021 -955.00
Jun 30, 2021 -5.15 Mn
Mar 31, 2021 890.00
Dec 31, 2020 551,014.00
Sep 30, 2020 3.65 Mn
Mar 31, 2020 -3.72 Mn
Dec 31, 2019 -5.62 Mn
Sep 30, 2019 -3.22 Mn
Jun 30, 2019 778,126.00
Mar 31, 2019 313,559.00
Dec 31, 2018 489,932.00
Sep 30, 2018 705,461.00
Jun 30, 2018 681,363.00
Mar 31, 2018 1.90 Mn